Managing multiple medications is a challenge for many individuals, particularly the elderly. One study by Almodóvar et al. (2019) found that among Medicare beneficiaries eligible for medication therapy management (MTM), 51% had used 11 or more medications. One approach to improving medication management is to use an appointment-based model (ABM) and other forms of medication…
Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery systems. Industry experts think these partnerships are smart moves to stay relevant in the rapidly-developing diabetes care space. The post The Surprising Rivalries-Turned-Friendships That Are…
To address the complicated healthcare landscape in the U.S., Pfizer launched a new direct-to-consumer virtual service called PfizerForAll. It follows Eli Lilly, which launched a similar product in January. The post Why Pfizer Is Dipping Into DTC Telehealth With PfizerForAll appeared first on MedCity News.
Rural Access Advancement Program designed to assist hospitals and hospital-owned skilled nursing home facilities in rural Georgia address short-term cash deficits
Sluggish margins and high costs have created a challenging environment for provider organizations. With the number of denied claims increasing significantly over the past few years, so has the time and resources needed to manage those denials. The post Building an Effective Denial Prevention Team to Mitigate Revenue Loss appeared first on MedCity News.
States can improve efficiency, reduce administrative costs, and, most importantly, enhance the quality of health care for its members by acting in these areas. The post Improve the Medicaid Provider Experience to Enhance Health Care appeared first on MedCity News.
By KIM BELLARD I feel much about synthetic biology as I do AI: I don’t really understand it from a technical point of view, but I sure am excited about its potential. Sometimes they even overlap, as I’ll discuss later. But I’ll start with some recent developments with bioplastics, a topic I have somehow never…
A team of researchers looks at SDOH challenges in the MSSP program
OMNY Health — a national data ecosystem that facilitates biotech and medical research — launched a data network consisting of EHR data from more than 645,000 GLP-1 users. The data network seeks to give OMNY’s life sciences and health system partners a vast source of GLP-1 data that is related to patient demographics and social…
Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is “inconsistent” with the 340B statute, according to HRSA. The post J&J’s Change to 340B Discounts is “Inconsistent” with Statute, HRSA Says appeared first on MedCity News.